COR - Cencora - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US03073E1055

Pharmaceuticals, Vaccines, Diagnostics, Healthcare Products, Blood Products

Cencora, Inc. is a leading pharmaceutical sourcing and distribution company that operates through two primary segments: U.S. Healthcare Solutions and International Healthcare Solutions.

The U.S. Healthcare Solutions segment is a comprehensive provider of pharmaceutical products, services, and solutions to a diverse range of customers, including acute care hospitals, health systems, retail pharmacies, mail order pharmacies, medical clinics, and long-term care facilities. The company distributes a broad portfolio of pharmaceuticals, over-the-counter healthcare products, home healthcare supplies, and equipment, as well as provides value-added services such as pharmacy management, staffing, and consulting services. Additionally, Cencora offers supply management software, packaging solutions, clinical trial support, product post-approval, and commercialization support services to its customers.

In the animal health sector, Cencora distributes pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets. The company also provides sales force services to manufacturers, helping them to reach a wider customer base.

Furthermore, Cencora's U.S. Healthcare Solutions segment offers specialized services to physicians and healthcare providers, including those who specialize in oncology and other disease states. The company distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products, and provides additional services to hospitals, dialysis clinics, and other healthcare providers.

The International Healthcare Solutions segment focuses on international pharmaceutical wholesale and related services, distributing pharmaceuticals, healthcare products, and services to pharmacies, doctors, health centers, and hospitals primarily in Europe. Cencora also provides global commercialization services and specialty transportation and logistics services for the biopharmaceutical industry.

Headquartered in Conshohocken, Pennsylvania, Cencora, Inc. was formerly known as AmerisourceBergen Corporation and changed its name in August 2023. The company was incorporated in 2001 and has since established itself as a leading player in the pharmaceutical sourcing and distribution industry.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for COR - Cencora  - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for COR - Cencora  - Stock Price & Dividends

COR Stock Overview

Market Cap in USD 47,771m
Sector Healthcare
Industry Medical Distribution
GiC SubIndustry Health Care Distributors
TER 0.00%
IPO / Inception 1995-04-04

COR Stock Ratings

Growth 5y 96.1
Fundamental 55.5
Dividend 56.5
Rel. Performance vs Sector -0.54
Analysts 4.11/5
Fair Price Momentum 267.50 USD
Fair Price DCF 505.63 USD

COR Dividends

Dividend Yield 12m 0.87%
Yield on Cost 5y 2.51%
Dividends CAGR 5y 4.20%
Payout Consistency 99.8%

COR Growth Ratios

Growth 12m 33.45%
Growth Correlation 12m 77%
Growth Correlation 3m 50%
CAGR 5y 23.55%
CAGR/Mean DD 5y 4.69
Sharpe Ratio 12m 1.71
Alpha vs SP500 12m 17.86
Beta vs SP500 5y weekly 0.59
ValueRay RSI 26.57
Volatility GJR Garch 1y 16.04%
Price / SMA 50 1.29%
Price / SMA 200 3.84%
Current Volume 1793.5k
Average Volume 20d 1150.8k

External Links for COR Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of COR stocks?
As of September 08, 2024, the stock is trading at USD 234.97 with a total of 1,793,480 shares traded.
Over the past week, the price has changed by -1.92%, over one month by -1.81%, over three months by -0.50% and over the past year by +33.42%.
What are the forecast for COR stock price target?
According to ValueRays Forecast Model, COR Cencora will be worth about 292.9 in September 2025. The stock is currently trading at 234.97. This means that the stock has a potential upside of +24.64%.
Issuer Forecast Upside
Wallstreet Target Price 263.4 12.1
Analysts Target Price 209.7 -10.8
ValueRay Target Price 292.9 24.6